Michael Coleman - Publications

Affiliations: 
University of Cambridge, Cambridge, England, United Kingdom 

100 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Yang S, Niou ZX, Enriquez A, LaMar J, Huang JY, Ling K, Jafar-Nejad P, Gilley J, Coleman MP, Tennessen JM, Rangaraju V, Lu HC. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Molecular Neurodegeneration. 19: 13. PMID 38282024 DOI: 10.1186/s13024-023-00690-9  0.463
2023 Groh J, Abdelwahab T, Kattimani Y, Hörner M, Loserth S, Gudi V, Adalbert R, Imdahl F, Saliba AE, Coleman M, Stangel M, Simons M, Martini R. Microglia-mediated demyelination protects against CD8 T cell-driven axon degeneration in mice carrying PLP defects. Nature Communications. 14: 6911. PMID 37903797 DOI: 10.1038/s41467-023-42570-2  0.468
2023 Mutschler C, Fazal SV, Schumacher N, Loreto A, Coleman MP, Arthur-Farraj P. Schwann cells are axo-protective after injury irrespective of myelination status in mouse Schwann cell-neuron cocultures. Journal of Cell Science. 136. PMID 37642648 DOI: 10.1242/jcs.261557  0.366
2023 Yang S, Niou ZX, Enriquez A, LaMar J, Huang JY, Ling K, Jafar-Nejad P, Gilley J, Coleman MP, Tennessen JM, Rangaraju V, Lu HC. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Research Square. PMID 37292715 DOI: 10.21203/rs.3.rs-2859584/v1  0.474
2023 Fazal SV, Mutschler C, Chen CZ, Turmaine M, Chen CY, Hsueh YP, Ibañez-Grau A, Loreto A, Casillas-Bajo A, Cabedo H, Franklin RJM, Barker RA, Monk KR, Steventon BJ, Coleman MP, et al. SARM1 detection in myelinating glia: / is dispensable for PNS and CNS myelination in zebrafish and mice. Frontiers in Cellular Neuroscience. 17: 1158388. PMID 37091921 DOI: 10.3389/fncel.2023.1158388  0.348
2023 Loreto A, Antoniou C, Merlini E, Gilley J, Coleman MP. NMN: The NAD Precursor at the Intersection Between Axon Degeneration and Anti-ageing Therapies. Neuroscience Research. PMID 36657725 DOI: 10.1016/j.neures.2023.01.004  0.405
2022 Llobet Rosell A, Paglione M, Gilley J, Kocia M, Perillo G, Gasparrini M, Cialabrini L, Raffaelli N, Angeletti C, Orsomando G, Wu PH, Coleman MP, Loreto A, Neukomm LJ. The NAD precursor NMN activates dSarm to trigger axon degeneration in . Elife. 11. PMID 36476387 DOI: 10.7554/eLife.80245  0.478
2022 Coleman MP. Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 19: 1133-1144. PMID 36207571 DOI: 10.1007/s13311-022-01297-6  0.378
2022 Ademi M, Yang X, Coleman MP, Gilley J. Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survival. Scientific Reports. 12: 13846. PMID 35974060 DOI: 10.1038/s41598-022-18052-8  0.448
2022 Crawford CL, Antoniou C, Komarek L, Schultz V, Donald CL, Montague P, Barnett SC, Linington C, Willison HJ, Kohl A, Coleman MP, Edgar JM. SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral Infection. Frontiers in Molecular Neuroscience. 15: 860410. PMID 35493328 DOI: 10.3389/fnmol.2022.860410  0.329
2022 Gould SA, Adalbert R, Milde S, Coleman M. Imaging Axonal Transport in Ex Vivo Central and Peripheral Nerves. Methods in Molecular Biology (Clifton, N.J.). 2431: 73-93. PMID 35412272 DOI: 10.1007/978-1-0716-1990-2_4  0.384
2021 Gould SA, Gilley J, Ling K, Jafar-Nejad P, Rigo F, Coleman M. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration. Cell Reports. 37: 110108. PMID 34910914 DOI: 10.1016/j.celrep.2021.110108  0.471
2021 Loreto A, Angeletti C, Gu W, Osborne A, Nieuwenhuis B, Gilley J, Arthur-Farraj P, Merlini E, Amici A, Luo Z, Hartley-Tassell L, Ve T, Desrochers LM, Wang Q, Kobe B, ... ... Coleman MP, et al. Neurotoxin-mediated --potent activation of the axon degeneration regulator SARM1. Elife. 10. PMID 34870595 DOI: 10.7554/eLife.72823  0.432
2021 Merlini E, Coleman MP, Loreto A. Mitochondrial dysfunction as a trigger of programmed axon death. Trends in Neurosciences. PMID 34852932 DOI: 10.1016/j.tins.2021.10.014  0.4
2021 Arthur-Farraj P, Coleman MP. Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34595734 DOI: 10.1007/s13311-021-01125-3  0.411
2021 Hopkins EL, Gu W, Kobe B, Coleman MP. A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity. Frontiers in Molecular Biosciences. 8: 703532. PMID 34307460 DOI: 10.3389/fmolb.2021.703532  0.46
2021 Gould SA, White M, Wilbrey AL, Pór E, Coleman MP, Adalbert R. Protection against oxaliplatin-induced mechanical and thermal hypersensitivity in Sarm1 mice. Experimental Neurology. 113607. PMID 33460644 DOI: 10.1016/j.expneurol.2021.113607  0.341
2020 Coleman MP. Axon Degeneration: Which Method to Choose? Methods in Molecular Biology (Clifton, N.J.). 2143: 3-12. PMID 32524468 DOI: 10.1007/978-1-0716-0585-1_1  0.428
2020 Coleman MP, Höke A. Programmed axon degeneration: from mouse to mechanism to medicine. Nature Reviews. Neuroscience. PMID 32152523 DOI: 10.1038/s41583-020-0269-3  0.381
2019 Adalbert R, Kaieda A, Antoniou C, Loreto A, Yang X, Gilley J, Hoshino T, Uga K, Makhija MT, Coleman MP. Novel HDAC6 inhibitors increase tubulin acetylation and rescue axonal transport of mitochondria in a model of Charcot-Marie-Tooth Type 2F. Acs Chemical Neuroscience. PMID 31845794 DOI: 10.1021/acschemneuro.9b00338  0.382
2019 Loreto A, Hill CS, Hewitt VL, Orsomando G, Angeletti C, Gilley J, Lucci C, Sanchez-Martinez A, Whitworth AJ, Conforti L, Dajas-Bailador F, Coleman MP. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration. Neurobiology of Disease. 104678. PMID 31740269 DOI: 10.1016/j.nbd.2019.104678  0.416
2019 White MA, Lin Z, Kim E, Henstridge CM, Pena Altamira E, Hunt CK, Burchill E, Callaghan I, Loreto A, Brown-Wright H, Mead R, Simmons C, Cash D, Coleman MP, Sreedharan J. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathologica Communications. 7: 166. PMID 31661035 DOI: 10.1186/s40478-019-0800-9  0.401
2019 Lukacs M, Gilley J, Zhu Y, Orsomando G, Angeletti C, Liu J, Yang X, Park J, Hopkin RJ, Coleman MP, Zhai RG, Stottmann RW. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence. Experimental Neurology. 112961. PMID 31136762 DOI: 10.1016/J.Expneurol.2019.112961  0.474
2019 Huppke P, Wegener E, Gilley J, Angeletti C, Kurth I, Drenth JPH, Stadelmann C, Barrantes-Freer A, Brück W, Thiele H, Nürnberg P, Gärtner J, Orsomando G, Coleman MP. Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia. Experimental Neurology. 112958. PMID 31132363 DOI: 10.1016/j.expneurol.2019.112958  0.434
2018 Gilley J, Mayer P, Yu G, Coleman MP. Low levels of NMNAT2 compromise axon development and survival. Human Molecular Genetics. PMID 30304512 DOI: 10.1093/hmg/ddy356  0.513
2018 White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z, Andrews S, Segonds-Pichon A, Metterville J, Saksida LM, Mead R, ... ... Coleman MP, et al. Publisher Correction: TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nature Neuroscience. PMID 29872124 DOI: 10.1038/S41593-018-0160-Y  0.512
2018 Adalbert R, Milde S, Durrant C, Ando K, Stygelbout V, Yilmaz Z, Gould S, Brion JP, Coleman MP. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport. Neurobiology of Aging. 68: 68-75. PMID 29729423 DOI: 10.1016/j.neurobiolaging.2018.03.033  0.47
2018 White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z, Andrews S, Segonds-Pichon A, Metterville J, Saksida LM, Mead R, ... ... Coleman MP, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nature Neuroscience. PMID 29556029 DOI: 10.1038/S41593-018-0113-5  0.597
2017 Gilley J, Ribchester RR, Coleman MP. Sarm1 Deletion, but Not Wld(S), Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy. Cell Reports. 21: 10-16. PMID 28978465 DOI: 10.1016/j.celrep.2017.09.027  0.69
2017 Di Stefano M, Loreto A, Orsomando G, Mori V, Zamporlini F, Hulse RP, Webster J, Donaldson LF, Gering M, Raffaelli N, Coleman MP, Gilley J, Conforti L. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo. Current Biology : Cb. PMID 28262487 DOI: 10.1016/J.Cub.2017.01.070  0.519
2016 Hung CO, Coleman MP. KIF1A mediates axonal transport of BACE1 and identification of independently moving cargoes in living SCG neurons. Traffic (Copenhagen, Denmark). PMID 27484852 DOI: 10.1111/tra.12428  0.385
2016 Hill CS, Coleman MP, Menon DK. Traumatic Axonal Injury: Mechanisms and Translational Opportunities. Trends in Neurosciences. PMID 27040729 DOI: 10.1016/J.Tins.2016.03.002  0.31
2015 Rodríguez-Martín T, Pooler AM, Lau DH, Mórotz GM, De Vos KJ, Gilley J, Coleman MP, Hanger DP. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons. Neurobiology of Disease. 85: 1-10. PMID 26459111 DOI: 10.1016/j.nbd.2015.10.007  0.333
2015 Gilley J, Orsomando G, Nascimento-Ferreira I, Coleman MP. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Reports. 10: 1974-81. PMID 25818290 DOI: 10.1016/j.celrep.2015.02.060  0.498
2015 Milde S, Adalbert R, Elaman MH, Coleman MP. Axonal transport declines with age in two distinct phases separated by a period of relative stability. Neurobiology of Aging. 36: 971-81. PMID 25443288 DOI: 10.1016/j.neurobiolaging.2014.09.018  0.428
2015 Godzik K, Coleman MP. The axon-protective WLD(S) protein partially rescues mitochondrial respiration and glycolysis after axonal injury. Journal of Molecular Neuroscience : Mn. 55: 865-71. PMID 25352062 DOI: 10.1007/s12031-014-0440-2  0.406
2015 Di Stefano M, Nascimento-Ferreira I, Orsomando G, Mori V, Gilley J, Brown R, Janeckova L, Vargas ME, Worrell LA, Loreto A, Tickle J, Patrick J, Webster JR, Marangoni M, Carpi FM, ... ... Coleman MP, et al. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death and Differentiation. 22: 731-42. PMID 25323584 DOI: 10.1038/Cdd.2014.164  0.705
2015 Adalbert R, Coleman MP. Review: Axon pathology in age-related neurodegenerative disorders. Neuropathology and Applied Neurobiology. 39: 90-108. PMID 23046254 DOI: 10.1111/j.1365-2990.2012.01308.x  0.31
2014 Milde S, Coleman MP. Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2). The Journal of Biological Chemistry. 289: 32858-70. PMID 25271157 DOI: 10.1074/jbc.M114.582338  0.456
2014 Marangoni M, Adalbert R, Janeckova L, Patrick J, Kohli J, Coleman MP, Conforti L. Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease. Neurobiology of Aging. 35: 2382-93. PMID 24906892 DOI: 10.1016/j.neurobiolaging.2014.04.024  0.531
2014 Conforti L, Gilley J, Coleman MP. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nature Reviews. Neuroscience. 15: 394-409. PMID 24840802 DOI: 10.1038/nrn3680  0.484
2014 Adalbert R, Milde S, Harwell C, Coleman M. P1-085: AXONAL TRANSPORT IN TGCRND8/P301L KI AND TAU NULL MICE Alzheimer's & Dementia. 10: P333-P334. DOI: 10.1016/j.jalz.2014.05.321  0.424
2013 Milde S, Gilley J, Coleman MP. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo. Bioarchitecture. 3: 133-40. PMID 24284888 DOI: 10.4161/bioa.27049  0.506
2013 Evans C, Cook SJ, Coleman MP, Gilley J. MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling. Plos One. 8: e76505. PMID 24124570 DOI: 10.1371/journal.pone.0076505  0.432
2013 Milde S, Fox AN, Freeman MR, Coleman MP. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo. Scientific Reports. 3: 2567. PMID 23995269 DOI: 10.1038/Srep02567  0.508
2013 Gilley J, Adalbert R, Yu G, Coleman MP. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 13410-24. PMID 23946398 DOI: 10.1523/JNEUROSCI.1534-13.2013  0.514
2013 Coleman MP. The challenges of axon survival: introduction to the special issue on axonal degeneration. Experimental Neurology. 246: 1-5. PMID 23769907 DOI: 10.1016/j.expneurol.2013.06.007  0.491
2013 Yang Y, Coleman M, Zhang L, Zheng X, Yue Z. Autophagy in axonal and dendritic degeneration. Trends in Neurosciences. 36: 418-28. PMID 23639383 DOI: 10.1016/J.Tins.2013.04.001  0.415
2013 Milde S, Gilley J, Coleman MP. Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. Plos Biology. 11: e1001539. PMID 23610559 DOI: 10.1371/journal.pbio.1001539  0.484
2013 Marangoni M, Adalbert R, Janeckova L, Patrick J, Kohli J, Coleman MP, Conforti L. Axonal swelling preceding neuronal degeneration characterise pathology in mouse models of Huntington's disease Experimental Gerontology. 48: 692. DOI: 10.1016/j.exger.2013.05.033  0.431
2012 Adalbert R, Morreale G, Paizs M, Conforti L, Walker SA, Roderick HL, Bootman MD, Siklós L, Coleman MP. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons. Neuroscience. 225: 44-54. PMID 22960623 DOI: 10.1016/j.neuroscience.2012.08.056  0.328
2012 Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, MacDonald JM, Ziegenfuss JS, Milde S, Hou YJ, Nathan C, ... ... Coleman M, et al. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science (New York, N.Y.). 337: 481-4. PMID 22678360 DOI: 10.1126/Science.1223899  0.469
2012 Court FA, Coleman MP. Mitochondria as a central sensor for axonal degenerative stimuli. Trends in Neurosciences. 35: 364-72. PMID 22578891 DOI: 10.1016/j.tins.2012.04.001  0.441
2012 Gilley J, Seereeram A, Ando K, Mosely S, Andrews S, Kerschensteiner M, Misgeld T, Brion JP, Anderton B, Hanger DP, Coleman MP. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiology of Aging. 33: 621.e1-621.e15. PMID 21492964 DOI: 10.1016/J.Neurobiolaging.2011.02.014  0.322
2011 Gilley J, Adalbert R, Coleman MP. Modelling early responses to neurodegenerative mutations in mice. Biochemical Society Transactions. 39: 933-8. PMID 21787326 DOI: 10.1042/BST0390933  0.329
2011 Conforti L, Janeckova L, Wagner D, Mazzola F, Cialabrini L, Di Stefano M, Orsomando G, Magni G, Bendotti C, Smyth N, Coleman M. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. The Febs Journal. 278: 2666-79. PMID 21615689 DOI: 10.1111/j.1742-4658.2011.08193.x  0.544
2011 Coleman M. Molecular Signaling. How Do Axons Die? Advances in Genetics. 73: 185-217. PMID 21310297 DOI: 10.1016/B978-0-12-380860-8.00005-7  0.474
2011 Meyer zu Horste G, Miesbach TA, Muller JI, Fledrich R, Stassart RM, Kieseier BC, Coleman MP, Sereda MW. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiology of Disease. 42: 1-8. PMID 21168501 DOI: 10.1016/j.nbd.2010.12.006  0.495
2011 Gasparini L, Crowther RA, Martin KR, Berg N, Coleman M, Goedert M, Spillantini MG. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiology of Aging. 32: 419-33. PMID 19356824 DOI: 10.1016/J.Neurobiolaging.2009.03.002  0.407
2010 Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo Journal of Neuroscience. 30: 13291-13304. PMID 20926655 DOI: 10.1523/Jneurosci.1189-10.2010  0.724
2010 Andrews S, Gilley J, Coleman MP. Difference Tracker: ImageJ plugins for fully automated analysis of multiple axonal transport parameters. Journal of Neuroscience Methods. 193: 281-7. PMID 20869987 DOI: 10.1016/j.jneumeth.2010.09.007  0.382
2010 Beirowski B, Nógrádi A, Babetto E, Garcia-Alias G, Coleman MP. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration. Journal of Neuropathology and Experimental Neurology. 69: 455-72. PMID 20418780 DOI: 10.1097/NEN.0b013e3181da84db  0.494
2010 Coleman MP, Freeman MR. Wallerian degeneration, wld(s), and nmnat. Annual Review of Neuroscience. 33: 245-67. PMID 20345246 DOI: 10.1146/Annurev-Neuro-060909-153248  0.503
2010 Gilley J, Coleman MP. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. Plos Biology. 8: e1000300. PMID 20126265 DOI: 10.1371/journal.pbio.1000300  0.504
2009 Beirowski B, Morreale G, Conforti L, Mazzola F, Di Stefano M, Wilbrey A, Babetto E, Janeckova L, Magni G, Coleman MP. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened. Neuroscience. 166: 201-11. PMID 20018231 DOI: 10.1016/j.neuroscience.2009.12.024  0.461
2009 Wong F, Fan L, Wells S, Hartley R, Mackenzie FE, Oyebode O, Brown R, Thomson D, Coleman MP, Blanco G, Ribchester RR. Axonal and neuromuscular synaptic phenotypes in WldS, SOD1G93A and ostes mutant mice identified by fiber-optic confocal microendoscopy Molecular and Cellular Neuroscience. 42: 296-307. PMID 19683573 DOI: 10.1016/J.Mcn.2009.08.002  0.73
2009 Conforti L, Wilbrey A, Morreale G, Janeckova L, Beirowski B, Adalbert R, Mazzola F, Stefano MD, Hartley R, Babetto E, Smith T, Gilley J, Billington RA, Genazzani AA, Ribchester RR, ... ... Coleman M, et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice Journal of Cell Biology. 184: 491-500. PMID 19237596 DOI: 10.1083/Jcb.200807175  0.691
2009 Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, Janeckova L, Magni G, Ribchester RR, Coleman MP. Non-nuclear WldS determines its neuroprotective efficacy for axons and synapses in vivo Journal of Neuroscience. 29: 653-668. PMID 19158292 DOI: 10.1523/JNEUROSCI.3814-08.2009  0.742
2009 Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, Misgeld T, Coleman MP. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain : a Journal of Neurology. 132: 402-16. PMID 19059977 DOI: 10.1093/Brain/Awn312  0.483
2009 Bridge KE, Berg N, Adalbert R, Babetto E, Dias T, Spillantini MG, Ribchester RR, Coleman MP. Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiology of Aging. 30: 309-21. PMID 17658198 DOI: 10.1016/J.Neurobiolaging.2007.06.002  0.714
2008 Beirowski B, Babetto E, Coleman MP, Martin KR. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model European Journal of Neuroscience. 28: 1166-1179. PMID 18783366 DOI: 10.1111/j.1460-9568.2008.06426.x  0.499
2008 Wilbrey AL, Haley JE, Wishart TM, Conforti L, Morreale G, Beirowski B, Babetto E, Adalbert R, Gillingwater TH, Smith T, Wyllie DJ, Ribchester RR, Coleman MP. VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Molecular and Cellular Neurosciences. 38: 325-40. PMID 18468455 DOI: 10.1016/J.Mcn.2008.03.004  0.668
2008 Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Coleman MP. P1-104: Long-term survival of dystrophic axons and their cell bodies in Alzheimer's disease pathology Alzheimer's & Dementia. 4: T237-T237. DOI: 10.1016/j.jalz.2008.05.691  0.344
2007 Wishart TM, Macdonald SH, Chen PE, Shipston MJ, Coleman MP, Gillingwater TH, Ribchester RR. Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene. Molecular Neurodegeneration. 2: 21. PMID 17971231 DOI: 10.1186/1750-1326-2-21  0.645
2007 Adalbert R, Gilley J, Coleman MP. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. Trends in Molecular Medicine. 13: 135-42. PMID 17344096 DOI: 10.1016/j.molmed.2007.02.004  0.412
2007 Conforti L, Fang G, Beirowski B, Wang MS, Sorci L, Asress S, Adalbert R, Silva A, Bridge K, Huang XP, Magni G, Glass JD, Coleman MP. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death and Differentiation. 14: 116-27. PMID 16645633 DOI: 10.1038/sj.cdd.4401944  0.556
2006 Adalbert R, Nógrádi A, Szabó A, Coleman MP. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy. The European Journal of Neuroscience. 24: 2163-8. PMID 17074042 DOI: 10.1111/j.1460-9568.2006.05103.x  0.475
2006 Gillingwater TH, Wishart TM, Chen PE, Haley JE, Robertson K, MacDonald SH, Middleton S, Wawrowski K, Shipston MJ, Melmed S, Wyllie DJ, Skehel PA, Coleman MP, Ribchester RR. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Human Molecular Genetics. 15: 625-35. PMID 16403805 DOI: 10.1093/Hmg/Ddi478  0.607
2006 Laser H, Conforti L, Morreale G, Mack TG, Heyer M, Haley JE, Wishart TM, Beirowski B, Walker SA, Haase G, Celik A, Adalbert R, Wagner D, Grumme D, Ribchester RR, ... ... Coleman MP, et al. The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Molecular Biology of the Cell. 17: 1075-84. PMID 16371511 DOI: 10.1091/mbc.E05-04-0375  0.61
2006 Adalbert R, Berg N, Babetto E, Spillantini MG, Goedert M, Coleman M. P1-084: Use of YFP imaging to study axon pathology in animal models of Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.459  0.353
2005 Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nature Reviews. Neuroscience. 6: 889-98. PMID 16224497 DOI: 10.1038/nrn1788  0.463
2005 Fang C, Bernardes-Silva M, Coleman MP, Perry VH. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS. Neuroscience. 135: 1107-18. PMID 16154290 DOI: 10.1016/J.Neuroscience.2005.06.078  0.47
2005 Coleman MP, Adalbert R, Beirowski B. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice. Journal of the Neurological Sciences. 233: 133-8. PMID 15899498 DOI: 10.1016/j.jns.2005.03.028  0.523
2005 Fischer LR, Culver DG, Davis AA, Tennant P, Wang M, Coleman M, Asress S, Adalbert R, Alexander GM, Glass JD. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiology of Disease. 19: 293-300. PMID 15837585 DOI: 10.1016/J.Nbd.2005.01.008  0.498
2005 Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves Bmc Neuroscience. 6. PMID 15686598 DOI: 10.1186/1471-2202-6-6  0.712
2005 Adalbert R, Gillingwater TH, Haley JE, Bridge K, Beirowski B, Berek L, Wagner D, Grumme D, Thomson D, Celik A, Addicks K, Ribchester RR, Coleman MP. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. The European Journal of Neuroscience. 21: 271-7. PMID 15654865 DOI: 10.1111/J.1460-9568.2004.03833.X  0.683
2005 Mi W, Beirowski B, Gillingwater TH, Adalbert R, Wagner D, Grumme D, Osaka H, Conforti L, Arnhold S, Addicks K, Wada K, Ribchester RR, Coleman MP. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice Brain. 128: 405-416. PMID 15644421 DOI: 10.1093/brain/awh368  0.725
2004 Beirowski B, Berek L, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice Journal of Neuroscience Methods. 134: 23-35. PMID 15102500 DOI: 10.1016/j.jneumeth.2003.10.016  0.709
2004 Laser H, Mack TG, Wagner D, Coleman MP. Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture. Journal of Neuroscience Research. 74: 906-16. PMID 14648596 DOI: 10.1002/jnr.10806  0.343
2003 Gillingwater TH, Ingham CA, Coleman MP, Ribchester RR. Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene. Journal of Anatomy. 203: 265-76. PMID 14529044 DOI: 10.1046/j.1469-7580.2003.00214.x  0.658
2003 Sievers C, Platt N, Perry VH, Coleman MP, Conforti L. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neuroscience Research. 46: 161-9. PMID 12767479 DOI: 10.1016/S0168-0102(03)00039-7  0.389
2003 Mi W, Glass JD, Coleman MP. Stable inheritance of an 85-kb triplication in C57BL/WldS mice. Mutation Research. 526: 33-7. PMID 12714180 DOI: 10.1016/S0027-5107(03)00011-3  0.357
2003 Ferri A, Sanes JR, Coleman MP, Cunningham JM, Kato AC. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Current Biology : Cb. 13: 669-73. PMID 12699624 DOI: 10.1016/S0960-9822(03)00206-9  0.486
2003 Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2833-9. PMID 12684470  0.514
2003 Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R. TheWldsMutation Delays Robust Loss of Motor and Sensory Axons in a Genetic Model for Myelin-Related Axonopathy The Journal of Neuroscience. 23: 2833-2839. DOI: 10.1523/JNEUROSCI.23-07-02833.2003  0.38
2002 Gillingwater TH, Thomson D, Mack TGA, Soffin EM, Mattison RJ, Coleman MP, Ribchester RR. Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wlds mutant and Ube4b/Nmnat transgenic mice Journal of Physiology. 543: 739-755. PMID 12231635 DOI: 10.1113/Jphysiol.2002.022343  0.691
2002 Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends in Neurosciences. 25: 532-7. PMID 12220882  0.398
2002 Mi W, Conforti L, Coleman MP. Genotyping methods to detect a unique neuroprotective factor (Wld(s)) for axons. Journal of Neuroscience Methods. 113: 215-8. PMID 11772443 DOI: 10.1016/S0165-0270(01)00501-5  0.5
2001 Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, ... ... Coleman MP, et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nature Neuroscience. 4: 1199-206. PMID 11770485 DOI: 10.1038/Nn770  0.719
2000 Conforti L, Tarlton A, Mack TG, Mi W, Buckmaster EA, Wagner D, Perry VH, Coleman MP. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proceedings of the National Academy of Sciences of the United States of America. 97: 11377-82. PMID 11027338 DOI: 10.1073/pnas.97.21.11377  0.316
Show low-probability matches.